<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>10(8)</volume><submitter>Putra AC</submitter><pubmed_abstract>Hypoxia-inducible factor-2α (HIF-2α, or EPAS1) is important for cancer progression, and is a putative biomarker for poor prognosis for non-small cell lung cancer (NSCLC). However, molecular mechanisms underlying the EPAS1 overexpression are not still fully understood. We explored a role of a single nucleotide polymorphism (SNP), rs13419896 located within intron 1 of the EPAS1 gene in regulation of its expression. Bioinformatic analyses suggested that a region including the rs13419896 SNP plays a role in regulation of the EPAS1 gene expression and the SNP alters the binding activity of transcription factors. In vitro analyses demonstrated that a fragment containing the SNP locus function as a regulatory region and that a fragment with A allele showed higher transactivation activity than one</pubmed_abstract><journal>PloS one</journal><pagination>e0134496</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4532412</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>The A Allele at rs13419896 of EPAS1 Is Associated with Enhanced Expression and Poor Prognosis for Non-Small Cell Lung Cancer.</pubmed_title><pmcid>PMC4532412</pmcid><pubmed_authors>Isobe T</pubmed_authors><pubmed_authors>Yamane Y</pubmed_authors><pubmed_authors>Eguchi H</pubmed_authors><pubmed_authors>Poellinger L</pubmed_authors><pubmed_authors>Putra AC</pubmed_authors><pubmed_authors>Gustine E</pubmed_authors><pubmed_authors>Tanimoto K</pubmed_authors><pubmed_authors>Nishiyama M</pubmed_authors><pubmed_authors>Lee KL</pubmed_authors><pubmed_authors>Hiyama K</pubmed_authors></additional><is_claimable>false</is_claimable><name>The A Allele at rs13419896 of EPAS1 Is Associated with Enhanced Expression and Poor Prognosis for Non-Small Cell Lung Cancer.</name><description>Hypoxia-inducible factor-2α (HIF-2α, or EPAS1) is important for cancer progression, and is a putative biomarker for poor prognosis for non-small cell lung cancer (NSCLC). However, molecular mechanisms underlying the EPAS1 overexpression are not still fully understood. We explored a role of a single nucleotide polymorphism (SNP), rs13419896 located within intron 1 of the EPAS1 gene in regulation of its expression. Bioinformatic analyses suggested that a region including the rs13419896 SNP plays a role in regulation of the EPAS1 gene expression and the SNP alters the binding activity of transcription factors. In vitro analyses demonstrated that a fragment containing the SNP locus function as a regulatory region and that a fragment with A allele showed higher transactivation activity than one</description><dates><release>2015-01-01T00:00:00Z</release><publication>2015</publication><modification>2026-05-30T00:42:09.679Z</modification><creation>2019-03-26T23:35:20Z</creation></dates><accession>S-EPMC4532412</accession><cross_references><pubmed>26263511</pubmed><doi>10.1371/journal.pone.0134496</doi></cross_references></HashMap>